Phase 1 Nodular Basal Cell Carcinoma Clinical Trials
2 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–2 of 2 trials
Recruiting
Phase 1Phase 2
A Study to Evaluate the Safety and Efficacy of EscharEx (EX-02) in the Treatment of Basal Cell Carcinoma
Superficial Basal Cell CarcinomaNodular Basal Cell Carcinoma
MediWound Ltd32 enrolled3 locationsNCT05157763
Completed
Phase 1
A phase I study of the Dz13 drug targeting the c-Jun gene in subjects with skin cance (nodular Basal Cell Carcinoma).
Nodular Basal Cell Carcinoma (BCC)
University of New South Wales9 enrolled1 locationACTRN12610000162011